3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Lymphoid
1
Gastrointestinal
1
Breast
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
24
Lymphoma
21
Lymphoma, Non-Hodgkin
20
Lymphoma, Large B-Cell, Diffuse
15
Lymphoma, Follicular
12
Neoplasms
8
Leukemia, Lymphocytic, Chronic, B-Cell
8
Lymphoma, Mantle-Cell
7
Lymphoma, B-Cell, Marginal Zone
7
Leukemia, Myeloid, Acute
7
Leukemia
7
Recurrence
6
Lymphoma, Large-Cell, Anaplastic
6
Hodgkin Disease
6
Burkitt Lymphoma
6
Lymphoma, T-Cell, Peripheral
5
Lymphoma, Extranodal NK-T-Cell
5
Myelodysplastic Syndromes
4
Multiple Myeloma
4
Lymphoma, T-Cell
4
Lymphoma, Large-Cell, Immunoblastic
4
Immunoblastic Lymphadenopathy
4
Breast Neoplasms
4
Waldenstrom Macroglobulinemia
3
Sarcoma
3
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Ovarian Neoplasms
3
Mycosis Fungoides
3
Melanoma
3
Lymphoma, T-Cell, Cutaneous
3
Interventions
Electroencephalography
1
Drug Therapy
1
Circumcision, Male
1
Analgesics, Opioid
1
Acupuncture Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Agnosia
×
Drug Therapy
×
Lymphoid
×
Clear all
NCT07152938
2025-09-15
AVR-CHEMO
Arab American University (Palestine)
Phase NA
Completed
150 enrolled